Seer (SEER) Cash & Equivalents (2020 - 2026)
Seer (SEER) recorded quarterly Cash & Equivalents of $47.3 million in Q1 2026, little changed quarter-over-quarter from $47.3 million in Q4 2025, and down 9.78% on a YoY basis from $52.4 million in Q1 2025.
Seer (SEER) Cash & Equivalents (2020 - 2026) Analysis & Trends
Seer's Cash & Equivalents history runs 7 years deep, the most recent figure standing at $47.3 million for Q1 2026.
- In Q1 2026, Cash & Equivalents fell 9.78% year-over-year to $47.3 million; the TTM figure through Mar 2026 stood at $47.3 million (down 9.78% YoY), while the FY2025 annual figure was $47.3 million, up 16.03% from the prior year.
- Cash & Equivalents was $47.3 million for Q1 2026 at Seer, roughly flat from $47.3 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $225.3 million in Q1 2022 to a low of $31.9 million in Q2 2024.
- Historically, Cash & Equivalents has averaged $58.5 million across 5 years, with a median of $47.3 million in 2026.
- The sharpest annual moves came in 2022 and 2024: Cash & Equivalents plunged 79.46% in 2022, then climbed 25.4% in 2024.
- A 5-year view of Cash & Equivalents shows it stood at $53.2 million in 2022, then sank by 38.92% to $32.5 million in 2023, then gained by 25.4% to $40.8 million in 2024, then gained by 16.03% to $47.3 million in 2025, then rose by 0.07% to $47.3 million in 2026.
- The last three Cash & Equivalents figures came in at $47.3 million (Q1 2026), $47.3 million (Q4 2025), and $45.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 32.30 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 1.91 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 286.70 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 2.77 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 18.44 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 7.15 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 5.49 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 558.94 Mn |
| 10 | Seer | 99.67 Mn | 99.67 Mn | 982,000.00 | 47.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 47.32 Mn |
| Dec 31, 2025 | 47.29 Mn |
| Sep 30, 2025 | 44.97 Mn |
| Jun 30, 2025 | 37.93 Mn |
| Mar 31, 2025 | 52.45 Mn |
| Dec 31, 2024 | 40.75 Mn |
| Sep 30, 2024 | 37.62 Mn |
| Jun 30, 2024 | 31.95 Mn |
| Mar 31, 2024 | 54.40 Mn |
| Dec 31, 2023 | 32.50 Mn |
| Sep 30, 2023 | 36.40 Mn |
| Jun 30, 2023 | 56.40 Mn |
| Mar 31, 2023 | 48.39 Mn |
| Dec 31, 2022 | 53.21 Mn |
| Sep 30, 2022 | 68.07 Mn |
| Jun 30, 2022 | 79.02 Mn |
| Mar 31, 2022 | 225.33 Mn |
| Dec 31, 2021 | 232.81 Mn |
| Sep 30, 2021 | 331.40 Mn |
| Jun 30, 2021 | 370.68 Mn |